Picture of Clariane SE logo

CLARI Clariane SE Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Annual cashflow statement for Clariane SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

C2019
December 31st
2020
December 31st
C2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line11642.112245-80.3
Depreciation
Non-Cash Items244266231246242
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-54.6-37.4-125-46.9-108
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities766795840862804
Capital Expenditures-326-520-529-622-484
Purchase of Fixed Assets
Other Investing Cash Flow Items-310-577-296-148-185
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-636-1,097-825-770-670
Financing Cash Flow Items-187-1836.71-215-174
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3351,11231.4-550-194
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-20581050.3-465-57.7